Article
Glycodelin As A Biomarker Of Advanced Lung Adenocarcinoma Brain Metastases In Patients…
Cancer Management and Research · 2019 · Ni Z, Zhang L, Zheng J, Su X, Zhang S
Key facts
| Title | Glycodelin As A Biomarker Of Advanced Lung Adenocarcinoma Brain Metastases In Patients Treated With EGFR Tyrosine Kinase Inhibitors |
|---|---|
| First author | Ni Z, Zhang L, Zheng J, Su X, Zhang S |
| Journal | Cancer Management and Research |
| Published | Nov 6, 2019 |
| DOI | 10.2147/CMAR.S216971 |
| Devices mentioned | 216971 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1